<PAGE> 1
------------------------------
OMB APPROVAL
------------------------------
OMB Number: 3235-0145
Expires: November 30, 1999
Estimated average burden
hours per response . . . 14.90
------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 2 )*
ASCENT PEDIATRICS, INC.
-------------------------------------------------------
(Name of Issuer)
COMMON STOCK, $.00004 PAR VALUE
-------------------------------------------------------
(Title of Class of Securities)
00004362X1
-------------------------------------------------------
(CUSIP Number)
-------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE> 2
SCHEDULE 13G
CUSIP NO. 00004362X1 PAGE 2 OF 16 PAGES
---------- -- --
- --------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Atlas Venture Fund II, L.P.
- --------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(A) [ ]
(B) [ ]
- --------------------------------------------------------------------------------
(3) SEC USE ONLY
- --------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware Limited Partnership
- --------------------------------------------------------------------------------
(5) SOLE VOTING POWER
0 shares
NUMBER OF ------------------------------------------------------
SHARES (6) SHARED VOTING POWER
BENEFICIALLY
OWNED BY 424,063 shares
EACH ------------------------------------------------------
REPORTING (7) SOLE DISPOSITIVE POWER
PERSON WITH
0 shares
------------------------------------------------------
(8) SHARED DISPOSITIVE POWER
424,063 shares
- --------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
424,063 shares
- --------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) [ ]
- --------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.4%
- --------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
- --------------------------------------------------------------------------------
<PAGE> 3
SCHEDULE 13G
CUSIP NO. 00004362X1 PAGE 3 OF 16 PAGES
---------- -- --
- --------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Atlas Venture Associates II, L.P.
- --------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(A) [ ]
(B) [ ]
- --------------------------------------------------------------------------------
(3) SEC USE ONLY
- --------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware Limited Partnership
- --------------------------------------------------------------------------------
(5) SOLE VOTING POWER
0 shares
NUMBER OF ------------------------------------------------------
SHARES (6) SHARED VOTING POWER
BENEFICIALLY
OWNED BY 424,063 shares
EACH ------------------------------------------------------
REPORTING (7) SOLE DISPOSITIVE POWER
PERSON WITH
0 shares
------------------------------------------------------
(8) SHARED DISPOSITIVE POWER
424,063 shares
- --------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
424,063 shares
- --------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) [ ]
- --------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.4%
- --------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
- --------------------------------------------------------------------------------
Page 3 of 16 Pages
<PAGE> 4
SCHEDULE 13G
CUSIP NO. 00004362X1 PAGE 4 OF 16 PAGES
---------- -- --
- --------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Christopher J. Spray
- --------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(A) [ ]
(B) [ ]
- --------------------------------------------------------------------------------
(3) SEC USE ONLY
- --------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United Kingdom
- --------------------------------------------------------------------------------
(5) SOLE VOTING POWER
0 shares
NUMBER OF ------------------------------------------------------
SHARES (6) SHARED VOTING POWER
BENEFICIALLY
OWNED BY 424,063 shares
EACH ------------------------------------------------------
REPORTING (7) SOLE DISPOSITIVE POWER
PERSON WITH
0 shares
------------------------------------------------------
(8) SHARED DISPOSITIVE POWER
424,063 shares
- --------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
424,063 shares
- --------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) [ ]
- --------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.4%
- --------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
- --------------------------------------------------------------------------------
Page 4 of 16 Pages
<PAGE> 5
SCHEDULE 13G
CUSIP NO. 00004362X1 PAGE 5 OF 16 PAGES
---------- -- --
- --------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Barry Fidelman
- --------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(A) [ ]
(B) [ ]
- --------------------------------------------------------------------------------
(3) SEC USE ONLY
- --------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
(5) SOLE VOTING POWER
0 shares
NUMBER OF ------------------------------------------------------
SHARES (6) SHARED VOTING POWER
BENEFICIALLY
OWNED BY 424,063 shares
EACH ------------------------------------------------------
REPORTING (7) SOLE DISPOSITIVE POWER
PERSON WITH
0 shares
------------------------------------------------------
(8) SHARED DISPOSITIVE POWER
424,063 shares
- --------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
424,063 shares
- --------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) [ ]
- --------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.4%
- --------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
- --------------------------------------------------------------------------------
Page 5 of 16 Pages
<PAGE> 6
SCHEDULE 13G
CUSIP NO. 00004362X1 PAGE 6 OF 16 PAGES
---------- -- --
- --------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Allan Ferguson
- --------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(A) [ ]
(B) [ ]
- --------------------------------------------------------------------------------
(3) SEC USE ONLY
- --------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
(5) SOLE VOTING POWER
0 shares
NUMBER OF ------------------------------------------------------
SHARES (6) SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0 shares
EACH ------------------------------------------------------
REPORTING (7) SOLE DISPOSITIVE POWER
PERSON WITH
0 shares
------------------------------------------------------
(8) SHARED DISPOSITIVE POWER
0 shares
- --------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0 shares
- --------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) [ ]
- --------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
- --------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
- --------------------------------------------------------------------------------
Page 6 of 16 Pages
<PAGE> 7
SCHEDULE 13G
CUSIP NO. 00004362X1 PAGE 7 OF 16 PAGES
---------- -- --
- --------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Jean-Francois Formela
- --------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(A) [ ]
(B) [ ]
- --------------------------------------------------------------------------------
(3) SEC USE ONLY
- --------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
France
- --------------------------------------------------------------------------------
(5) SOLE VOTING POWER
0 shares
NUMBER OF ------------------------------------------------------
SHARES (6) SHARED VOTING POWER
BENEFICIALLY
OWNED BY 424,063 shares
EACH ------------------------------------------------------
REPORTING (7) SOLE DISPOSITIVE POWER
PERSON WITH
0 shares
------------------------------------------------------
(8) SHARED DISPOSITIVE POWER
424,063 shares
- --------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
424,063 shares
- --------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) [ ]
- --------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.4%
- --------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
- --------------------------------------------------------------------------------
Page 7 of 16 Pages
<PAGE> 8
SCHEDULE 13G
Item 1(a). NAME OF ISSUER: Ascent Pediatrics, Inc.
Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
187 Ballardvale Street, Suite B125, Wilmington, Massachusetts
01887.
Item 2(a). NAMES OF PERSONS FILING: Atlas Venture Fund II, L.P., Atlas
Venture Associates II, L.P., Christopher J. Spray, Barry
Fidelman, Allan Ferguson and Jean-Francois Formela.
Atlas Venture Associates II, L.P. is the sole general partner
of Atlas Venture Fund II, L.P. Messrs. Spray, Fidelman and
Formela are the individual general partners of Atlas Venture
Associates II, L.P. Mr. Ferguson was formerly a general
partner of Atlas Venture Associates II, L.P.
Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
The address of the principal business office of Atlas Venture
Fund II, L.P., Atlas Venture Associates II, L.P. and Messrs.
Spray, Fidelman, Ferguson and Formela is Atlas Venture, 222
Berkeley Street, Boston, Massachusetts 02116.
Item 2(c). CITIZENSHIP: Atlas Venture Fund II, L.P. and Atlas Venture
Associates II, L.P. are each a limited partnership organized
under the laws of the State of Delaware. Mr. Spray is a
citizen of the United Kingdom. Messrs. Fidelman and Ferguson
are citizens of the United States. Mr. Formela is a citizen of
France.
Item 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, $.00004 par value.
Item 2(e). CUSIP NUMBER: 00004362X1
Item 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR
13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:
Not Applicable.
Item 4. OWNERSHIP.
Not Applicable.
Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
[x] Each of Atlas Venture Fund II, L.P. and Atlas Venture
Associates II, L.P. and each of Messrs. Spray, Fidelman and
Formela, in their capacities as individual general partners of
Atlas Venture Associates II, L.P., may be deemed to own
beneficially 424,063 shares of Common Stock as of December 31,
1999, which is five percent or less of the Common Stock of
Ascent Pediatrics, Inc. Mr. Ferguson may be deemed to own
beneficially no shares of Common Stock as of December 31,
1999.
Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER
PERSON.
Not Applicable.
<PAGE> 9
Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
COMPANY.
Not Applicable.
Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not Applicable. The reporting persons expressly disclaim
membership in a "group" as defined in Rule 13d-1(b)(1)(ii)(J).
Item 9. NOTICE OF DISSOLUTION OF GROUP.
Not Applicable.
Item 10. CERTIFICATIONS.
Not Applicable. This statement on Schedule 13G is not filed
pursuant to Rule 13d-1(b) or Rule 13d-1(c).
Page 9 of 16 Pages
<PAGE> 10
SIGNATURES
After reasonable inquiry and to the best of our knowledge and belief,
we certify that the information set forth in this statement is true, complete
and correct. We also hereby agree to file this statement jointly pursuant to the
Agreement listed on EXHIBIT 1 hereto.
Dated: February 10, 2000
ATLAS VENTURE FUND II, L.P. *
---------------------------------------
Christopher J. Spray
By: Atlas Venture Associates II, L.P.
*
---------------------------------------
Allan Ferguson
By: *
------------------------------
Christopher J. Spray, *
General Partner ---------------------------------------
Barry Fidelman
ATLAS VENTURE ASSOCIATES II, L.P. *
---------------------------------------
Jean-Francois Formela
By: *
------------------------------
Christopher J. Spray,
General Partner
* The undersigned attorney-in-fact, by signing her name below, does hereby
sign this statement on behalf of the above indicated filers pursuant to
Powers of Attorney filed hereto as EXHIBIT 2.
/s/ Jeanne Larkin Henry
------------------------------
Jeanne Larkin Henry
Attorney-in-fact
Page 10 of 16 Pages
<PAGE> 11
EXHIBIT 1
AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934,
the undersigned hereby agree that only one statement containing the information
required by Schedule 13G need be filed with respect to the ownership by each of
the undersigned of shares of Common Stock of Ascent Pediatrics, Inc.
This agreement may be executed in any number of counterparts, each of
which shall be deemed an original.
EXECUTED this 10th day of February, 2000.
ATLAS VENTURE FUND II, L.P. *
---------------------------------------
Christopher J. Spray
By: Atlas Venture Associates II, L.P.
*
---------------------------------------
Allan Ferguson
By: *
------------------------------
Christopher J. Spray, *
General Partner ---------------------------------------
Barry Fidelman
ATLAS VENTURE ASSOCIATES II, L.P. *
---------------------------------------
Jean-Francois Formela
By: *
------------------------------
Christopher J. Spray,
General Partner
* The undersigned attorney-in-fact, by signing her name below, does hereby
sign this statement on behalf of the above indicated filers pursuant to
Powers of Attorney filed hereto as EXHIBIT 2.
/s/ Jeanne Larkin Henry
------------------------------
Jeanne Larkin Henry
Attorney-in-fact
Page 11 of 16 Pages
<PAGE> 12
EXHIBIT 2
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature
appears below hereby constitutes and appoints each and any of Christopher J.
Spray and Jeanne Larkin Henry his true and lawful attorney-in-fact and agent,
with full power of substitution and resubstitution, for him and in his name,
place and stead, in any and all capacities (until revoked in writing) to sign
any and all instruments, certificates and documents required to be executed on
behalf of himself individually or on behalf of each or any of Atlas Venture
Fund, L.P., Atlas Venture Associates, L.P., Atlas Venture Partners III, B.V.,
Atlas Venture Fund II, L.P., Atlas Venture Associates II, L.P., Atlas Venture
Europe Fund B.V., Atlas InvesteringsGroep N.V., and Atlas Venture Beheer II B.V.
pursuant to sections 13 and 16 of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), and any and all regulations promulgated
thereunder, and to file the same, with all exhibits thereto, and any other
documents in connection therewith, with the Securities and Exchange Commission,
and with any other entity when and if such is mandated by the Exchange Act or by
the By-laws of the National Association of Securities Dealers, granting unto
said attorney-in-fact and agent full power and authority to do and perform each
and every act and thing requisite and necessary fully to all intents and
purposes as he might or could do in person thereby ratifying and confirming all
that said attorney-in-fact and agent, or his substitute or substitutes, may
lawfully do or cause to be done by virtue hereof.
[REMAINDER OF PAGE LEFT BLANK INTENTIONALLY]
[SIGNATURE PAGE FOLLOWS IMMEDIATELY]
Page 12 of 16 pages
<PAGE> 13
IN WITNESS WHEREOF, this Power of Attorney has been signed as of the 31st
day of January, 1997.
/s/ Christopher J. Spray
-----------------------------------
Christopher J. Spray
Commonwealth of Massachusetts)
) ss:
County of Suffolk )
On this 31st day of January, 1997, before me personally came Christopher
J. Spray, known to me to be the person described and who executed the foregoing
instrument that he acknowledged that he executed the same.
[Notary Seal] /s/ Elizabeth A. LeBlanc
-----------------------------------
Notary Public
My commission expires: July 3, 1998
Page 13 of 16 pages
<PAGE> 14
IN WITNESS WHEREOF, this Power of Attorney has been signed as of the 31st
day of January, 1997.
/s/ Barry Fidelman
-----------------------------------
Barry Fidelman
Commonwealth of Massachusetts)
) ss:
County of Suffolk )
On this 31st day of January, 1997, before me personally came Barry
Fidelman, known to me to be the person described and who executed the foregoing
instrument that he acknowledged that he executed the same.
[Notary Seal] /s/ Elizabeth A. LeBlanc
-----------------------------------
Notary Public
My commission expires: July 3, 1998
Page 14 of 16 Pages
<PAGE> 15
IN WITNESS WHEREOF, this Power of Attorney has been signed as of the 31st
day of January, 1997.
/s/ Allan R. Ferguson
-----------------------------------
Allan R. Ferguson
Commonwealth of Massachusetts)
) ss:
County of Suffolk )
On this 31st day of January, 1997, before me personally came Allan R.
Ferguson, known to me to be the person described and who executed the foregoing
instrument that he acknowledged that he executed the same.
[Notary Seal] /s/ Elizabeth A. LeBlanc
-----------------------------------
Notary Public
My commission expires: July 3, 1998
Page 15 of 16 Pages
<PAGE> 16
IN WITNESS WHEREOF, this Power of Attorney has been signed as of the 31st
day of January, 1997.
/s/ Jean-Francois Formela
-----------------------------------
Jean-Francois Formela
Commonwealth of Massachusetts)
) ss:
County of Suffolk )
On this 31st day of January, 1997, before me personally came Jean-Francois
Formela, known to me to be the person described and who executed the foregoing
instrument that he acknowledged that he executed the same.
[Notary Seal] /s/ Elizabeth A. LeBlanc
-----------------------------------
Notary Public
My commission expires: July 3, 1998
Page 16 of 16 Pages
